AGILYSYS INC financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data AGILYSYS INC files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2016	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026
Revenue	128	127	141	161	137	163	198	237	276	319
Cost of revenue	63.9	62.9	67	79.8	47.8	61.1	77.2	93.2	104	119
Gross profit	63.8	64.4	73.9	81	89.4	102	121	144	172	200
Research and development	29	27.9	37.8	41.5	55.3	46.3	50.3	56.7	62.4	72.7
Selling, general and administrative		76.5	87	115	110	95.2	108	129
Selling and marketing	20.8	18.1	19.6	19.9	14.2	14.7	22.7	28.4	33.1	39.8
General and administrative	19.9	24	23.1	24.4	33.3	27.7	30.7	36.3	40.8	42.2
Operating expenses	75.2	76.5	87				108	129	149	157
Operating income	-11.4	-12.1	-13.1	-34.1	-21	6.32	12.9	15.8	22.6	43
Interest expense	0.02	0.01	0.01	0.01	0.02	0.01	0	0	1.53	0.49
Interest income	0.16	0.1	0.34	0.38	0.11	0.06	2.19	5.08	3.78	1.99
Other non-operating income	-0.22	0.39	-0.19	-0.18	-0.34	0.15	0.7	-0.15	0.79	3.89
Pre-tax income	-11.5	-11.6	-12.9	-33.9	-21.2	6.51	15.8	20.7	25.6	48.4
Income tax	0.24	-3.25	0.22	0.2	-0.21	0.03	1.18	-65.5	2.41	9.62
Income from continuing operations		-8.35	-13.2	-34.1	-21	6.48	14.6	86.2	23.2	38.8
Net income	-11.7	-8.35	-13.2	-34.1	-21	6.48	14.6	86.2	23.2	38.8
EBITDA	-9	-9.45	-10.6	-31.5	-18.1	8.53	14.6	19.6	26.3	46.9
EPS, basic	-0.52	-0.37	-0.57	-1.47	-1.01	0.19	0.52	3.31	0.84	1.39
EPS, diluted	-0.52	-0.37	-0.57	-1.47	-1.01	0.18	0.49	3.17	0.82	1.37
Shares, basic (weighted)	22.6	0.02	0.02	23.2	23.5	24.4	24.7	25.7	27.5	27.9
Shares, diluted (weighted)	22.6	22.8	23	23.2	23.5	25.5	25.9	26.8	28.3	28.4

Balance sheet

	FY2016	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026
Cash and equivalents	49.3	39.9	40.8	46.7	99.2	97	113	145	73	117
Receivables	15.6	16.4	27	35.9	25.7	25.2	22.4	29.4	31.5	43.1
Inventory	2.21	2	2.04	3.89	1.18	6.94	9.77	4.59	5.17	7.53
Other current assets	6.46	5.59	6.27	4.87	4.8	5.42	7.42	0.4	1.2	0.12
Total current assets	73.5	63.9	79	93.4	133	136	155	189	124	184
Property, plant and equipment	16	17.5	15.8	12.2	8.79	6.35	14.6	17.9	16.7	14
Lease right-of-use assets			0	13.8	12.2	9.89	12.7	18.4	17.1	13.8
Goodwill	19.6	19.6	19.6	19.6	19.6	32.8	32.6	32.8	131	134
Intangible assets	8.53	8.48	8.44	8.4	8.4	20.2	18.1	17	70.8	66.4
Other non-current assets	2.63	2.48	5.68	6.31	5.8	6.15	7.53	8.06	9.05	11.3
Total assets	167	157	164	155	190	214	243	350	434	482
Accounts payable	8.7	8.4	4.72	13.4	6.35	9.77	9.42	9.42	12.4	12.4
Accrued liabilities	8.33	9.24	14.4	9.03	11.4	10.6	13.7	19.5	22.3	24.3
Deferred revenue	29.2	26.8	38.7
Total current liabilities	46.3	44.6	57.8	69.4	61.2	71.5	78.5	89.4	111	125
Long-term debt								0	24	0
Lease liabilities			0	10.6	8.6	5.65	13.5	19.6	17.3	13.7
Other non-current liabilities	4	3.91	4.26	1.86	3.86	3.3	4.02	4.42	5.17	5.76
Total liabilities	53.6	48.8	63	82.8	110	117	134	114	168	155
Total debt								0	24	0
Paid-in capital	-5.78	-1.91	0.78	5.49	37.3	50	53	94.7	110	132
Retained earnings	113	104	93.1	59	35.4	40	52.8	138	161	200
Treasury stock	-2.52	-2.49	-2.43	-2.4	-2.28	-2.06	-1.88	-1.79	-1.6	-1.55
Other comprehensive income	-0.2	-0.26	-0.26	0.2	0.04	-0.06	-4.03	-4.17	-13.3	-13.1
Shareholders' equity	114	108	101	71.8	79.9	97.3	109	236	266	327
Total equity	114	108	101	71.8	79.9	97.3	109	236	266	327
Total liabilities and equity	167	157	164	155	190	214	243	350	434	482
Shares outstanding	23.2	23.3	23.5	23.6	24	24.7	25.3	27.4	28	28.2

Cash flow statement

	FY2016	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026
Net income	-11.7	-8.35	-13.2	-34.1	-21	6.48	14.6	86.2	23.2	38.8
Depreciation and amortization	2.41	2.63	2.5	2.57	2.83	2.21	1.77	3.9	3.68	3.84
Stock-based compensation	2.43	4.69	4.38	5.21	40.1	14.5	13	14.1	17.8	21.8
Deferred income tax		-3.09	0.31	-0.36	-0.96	-0.93	-0.18	-66.4	0.43	6.92
Change in receivables	6.37	-0.72	-7.54	-8.97	10.4	2.55	2.54	-7	-0.57	-11.4
Change in inventory	0.48	0.23	-0.05	-1.83	2.75	-5.76	-2.9	5.19	-0.56	-2.35
Change in payables	0.55	0.13	-3.51	8.59	-7.02	3.42	-1.58	0.97	2.19	0.07
Cash from operations	3.43	6.87	7.24	10.6	28.4	28.5	34.5	48.2	55.1	70
Capital expenditures	-4.16	-6.14	-3.32	-3.42	-1.39	-1.2	-7.24	-8.13	-2.78	-1.85
Acquisitions	0			0	0	-24.5	0.4	0	-146	0
Purchases of investments	0
Sales and maturities of investments	0
Cash from investing	-13.9	-15.1	-5.53	-3.45	-1.39	-25.7	-6.87	-7.6	-149	-1.85
Debt repaid	-0.12	-0.12	-0.12	-0.02	-0.02	-0.02	-0	-0	0	0
Stock issued	0
Cash from financing	-0.85	-1.3	-0.77	-1.12	25.3	-4.9	-11.1	-8.56	21.9	-24.5
Exchange rate effect	-0.07	0.19	-0.11	-0.13	0.2	-0.1	-0.63	0.02	-0.34	0.17
Net change in cash	-11.4	-9.31	0.83	5.88	52.5	-2.21	15.9	32	-71.9	43.9
Free cash flow	-0.73	0.73	3.92	7.16	27	27.3	27.2	40.1	52.3	68.1
Interest paid							0	0	1.38	0.44
Income taxes paid	0.02	-0.23	0.41	0.69	0.46	0.79	1.16	1.73	1.93	2.07

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $99.64 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	63.1%	Gross profit / revenue.
Operating margin	14.6%	Operating income / revenue.
EBITDA margin	15.7%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	16.5%	Pre-tax income / revenue.
Net margin	13.0%	Net income / revenue.
FCF margin	24.4%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	24.9%	Cash from operations / revenue.
Effective tax rate	21.1%	Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)	12.7%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	9.1%	Net income / average total assets.
Return on invested capital (ROIC)	17.7%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
R&D / revenue	22.9%	Research and development expense / revenue.
Stock-based pay / revenue	6.9%	Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue	0.5%	Capital expenditures / revenue.
D&A / revenue	1.1%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	15.9%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	17.3%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	18.4%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	16.2%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	18.3%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	17.5%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y	90.4%	Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y	49.5%	Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA growth, 1y	78.4%	EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y	47.4%	Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income growth, 1y	67.0%	Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y	38.6%	Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS growth, 1y	67.1%	EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y	40.9%	Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow growth, 1y	27.0%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y	26.6%	Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y	19.8%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y	30.2%	Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y	35.8%	Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow CAGR, 5y	20.3%	Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y	22.9%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	44.1%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	32.5%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	10.9%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	25.6%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	20.5%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	0.5%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	3.1%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	3.9%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	1.74x	Current assets / current liabilities.
Quick ratio	1.53x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	1.18x	(Cash + short-term investments) / current liabilities.
Liabilities / assets	28.4%	Total liabilities / total assets.
Interest coverage	139x	Operating income / interest expense.
Working capital	$77.6M	Current assets - current liabilities.
Goodwill and intangibles / assets	41.3%	(Goodwill + intangible assets) / total assets.
Tangible book value	$143.0M	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	0.70x	Revenue / average total assets.
Fixed asset turnover	24.7x	Revenue / average property, plant and equipment.
Inventory turnover	15.4x	Cost of revenue / average inventory.
Days inventory	24 days	365 x average inventory / cost of revenue.
Receivables turnover	9.01x	Revenue / average receivables.
Days sales outstanding	40 days	365 x average receivables / revenue.
Days payables	38 days	365 x average accounts payable / cost of revenue.
Cash conversion cycle	26 days	Days inventory + days sales outstanding - days payables.
FCF conversion	187.5%	Free cash flow / net income, when net income is positive.
Capex / operating cash flow	2.1%	Capital expenditures / cash from operations, when that is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	$1.51	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$11.62	Revenue / diluted weighted shares.
FCF per share	$2.83	Free cash flow / diluted weighted shares.
Operating cash flow per share	$2.89	Cash from operations / diluted weighted shares.
Book value per share	$12.00	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	$5.07	Tangible book value / shares outstanding.
Cash per share	$4.39	(Cash + short-term investments) / shares outstanding.

Valuation

Metric	Value	How it is calculated
Market cap	$2.81B	Share price x shares outstanding.
Enterprise value	$2.69B	Market cap + total debt - cash - short-term investments.
P/E	65.5x	Market cap / net income. Only when net income is positive.
P/S	8.51x	Market cap / revenue.
P/B	8.31x	Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book	19.7x	Market cap / tangible book value, when positive.
P/FCF	34.9x	Market cap / free cash flow. Only when free cash flow is positive.
P/OCF	34.2x	Market cap / cash from operations, when positive.
EV/Sales	8.13x	Enterprise value / revenue.
EV/EBIT	55.7x	Enterprise value / operating income, when both are positive.
EV/EBITDA	51.7x	Enterprise value / EBITDA, when both are positive.
EV/FCF	33.4x	Enterprise value / free cash flow, when both are positive.
FCF yield	2.9%	Free cash flow / market cap.
Earnings yield	1.5%	Net income / market cap (the inverse of P/E).
PEG	1.60x	P/E / EPS growth per year over 3 years (in percent). Only when both are positive.

What was AGILYSYS INC's revenue in fiscal 2026?

AGILYSYS INC reported revenue of $319.3M for fiscal 2026, 15.9% higher than the year before.

Was AGILYSYS INC profitable in fiscal 2026?

Yes. Net income was $38.8M, a net margin of 12.1%.

How much free cash flow did AGILYSYS INC generate in fiscal 2026?

Cash from operations of $70.0M minus capital expenditures of $1.8M left free cash flow of $68.1M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to AGILYSYS INC